Filter Results:
(2,547)
Show Results For
- All HBS Web
(5,357)
- People (16)
- News (1,978)
- Research (2,547)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,906)
Show Results For
- All HBS Web
(5,357)
- People (16)
- News (1,978)
- Research (2,547)
- Events (3)
- Multimedia (222)
- Faculty Publications (1,906)
Sort by
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Bowes adapted its approach to employee health amid rising health care costs, shifting employer attitudes towards health benefits and a rapidly... View Details
Keywords: Martha Lagace
- August 2017 (Revised July 2018)
- Case
MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work
By: Elie Ofek and Amanda Dai
In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to... View Details
Keywords: Health Care and Treatment; Product Launch; Product Positioning; Marketing Strategy; Adoption; Pharmaceutical Industry
Ofek, Elie, and Amanda Dai. "MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work." Harvard Business School Case 518-031, August 2017. (Revised July 2018.)
- January 2007 (Revised December 2007)
- Case
PSI: Social Marketing Clean Water
By: V. Kasturi Rangan, Nava Ashraf and Marie Bell
Senior management at PSI, arguably the world's largest and most successful social marketer with impressive achievements in the field of family planning, HIV/AIDS, and malaria prevention must determine what to do about their slow-to-take-off clean water initiative.... View Details
Keywords: Investment Funds; Health Care and Treatment; Social Marketing; Natural Environment; Social Enterprise; Business Strategy
Rangan, V. Kasturi, Nava Ashraf, and Marie Bell. "PSI: Social Marketing Clean Water." Harvard Business School Case 507-052, January 2007. (Revised December 2007.) (Request a courtesy copy.)
- 2018
- Working Paper
Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices
By: Prithwiraj Choudhury and Tarun Khanna
We exploit a natural experiment to study how codifying information about prior innovation affects subsequent innovation. A codified database of traditional Indian herbal formulations was adopted by the European Patent Office (EPO) and the U.S. Patent and Trademark... View Details
Keywords: Patents; Plant-Based Agribusiness; Ethnicity; Health Care and Treatment; Pharmaceutical Industry; Agriculture and Agribusiness Industry; China; India
Choudhury, Prithwiraj, and Tarun Khanna. "Information Provision and Innovation: Natural Experiment of Herbal Patent Prior Art Adoption at the United States and European Patent Offices." Harvard Business School Working Paper, No. 14-079, February 2014. (Revised January 2018.)
- 20 Mar 2018
- First Look
First Look at New Research and Ideas, March 20, 2018
link: https://www.hbs.edu/faculty/Pages/item.aspx?num=54267 February 6, 2018 Harvard Business Review What Could Amazon's Approach to Health Care Look Like? By: Huckman, Robert S. Abstract—No abstract... View Details
Keywords: Sean Silverthorne
- 03 Apr 2012
- First Look
First Look: April 3
leadership development programs for residents. The authors first present a definition of clinical leadership and highlight evidence that effective frontline clinical leadership improves both clinical outcomes and satisfaction for patients and providers. The authors... View Details
Keywords: Carmen Nobel
- 23 Apr 2001
- Research & Ideas
Brand Power from Wedgwood to Dell: Part Two
decades mixing and selling skin care formulas before she undertook to build a national market for her products. Howard Schultz did not grow up drinking specialty coffee, but as soon as he was introduced to the business, he learned as much... View Details
Keywords: by Martha Lagace
- March 1990 (Revised March 1992)
- Case
New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign
By: V. Kasturi Rangan and Sohel Karim
Describes the background leading to the development of an advertising campaign to help prevention of AIDS in New York City. The three television networks, however, for various reasons reject the campaign, to the dismay of Saatchi & Saatchi executives. View Details
Keywords: Advertising Campaigns; Growth and Development; Health Care and Treatment; Marketing Communications; Failure; Advertising Industry; New York (city, NY)
Rangan, V. Kasturi, and Sohel Karim. "New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign." Harvard Business School Case 590-036, March 1990. (Revised March 1992.)
- March 2000
- Case
Heartport, Inc.
By: Gary P. Pisano and Shoshana Dobrow
Heartport, an entrepreneurial medical device maker, has introduced several innovative systems for conducting less-invasive cardiac surgery. Despite initially high expectations, the company has struggled to get its technology adopted by cardiac surgeons. The company's... View Details
Keywords: History; Product Positioning; Knowledge Acquisition; Corporate Entrepreneurship; Technology Adoption; Health Care and Treatment
Pisano, Gary P., and Shoshana Dobrow. "Heartport, Inc." Harvard Business School Case 600-020, March 2000.
- 30 Sep 2002
- Research & Ideas
Use the Psychology of Pricing To Keep Customers Returning
same concept can be applied to health care. In its current form, most of us pay for blanket health care coverage that entitles us to a number of periodic services such as... View Details
Keywords: by Manda Mahoney
- May 2025
- Teaching Note
The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation
By: Tsedal Neeley
Teaching Note for HBS Case No. 425-720. Florian Hillen, co-founder and CEO of VideaHealth, a startup using artificial intelligence (AI) to detect dental conditions on x-rays, spent the early years of his company laying the groundwork for an AI factory. This AI factory,... View Details
- 15 Sep 2009
- First Look
First Look: September 15
the director and the quality of the prior LBO experience. This effect is robust to the most likely alternative explanations and supports the idea that directors and social networks play an influential role in change-of-control... View Details
Keywords: Martha Lagace
- November 2024
- Background Note
Social Enterprise in the MENA Region
By: Brian Trelstad and Ahmed Dahawy
This research note provides an overview of the socio-economic landscape of social enterprise in the Middle East and North Africa. It highlights the diversity of players in the region including social enterprise organizations (in their many forms) and supporting... View Details
Keywords: MENA; Non-Governmental Organizations; Nonprofit Organizations; Civil Society or Community; Social Issues; Diasporas; Social Entrepreneurship; Cultural Entrepreneurship; Environmental Sustainability; Geographic Scope; Health Care and Treatment; Philanthropy and Charitable Giving; Business and Community Relations; Business and Government Relations; Social and Collaborative Networks; Demographics; Health Industry; Health Industry; Health Industry; Egypt; Morocco; North Africa; Tunisia; Jordan; Lebanon; Saudi Arabia; United Arab Emirates; Dubai; Middle East
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
- 03 Mar 2015
- First Look
First Look: March 3
Abstract—Improving the way we pay for health care must be a central component in health care reform. Payment reform must link provider... View Details
Keywords: Sean Silverthorne
- 14 Dec 2011
- Research & Ideas
The New Measures for Improving Nonprofit Performance
speak the same language for the most part. In the social sector we don't have nearly that degree of agreement over what constitutes useful, common metrics, even in subsectors like health care, education, and the environment. At the moment... View Details
Keywords: by Julia Hanna
- 11 Oct 2004
- Research & Ideas
Four Ways to Create Lasting Change
Clinics in Minnesota. That effort produced enduring behavioral and cultural changes regarding an issue (medical errors) that has proven very difficult to address for many health care institutions. Moving... View Details
Keywords: by Martha Lagace
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details
Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)
- January 2018
- Case
Spark Therapeutics: Pioneering Gene Therapy
By: Robert F. Higgins and Tina Liu
Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy
Higgins, Robert F., and Tina Liu. "Spark Therapeutics: Pioneering Gene Therapy." Harvard Business School Case 818-059, January 2018.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.